 | Galectin Therapeutics Inc. (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 17,000 Shares
www.americanbankingnews.com - October 15 at 8:46 AM |
| Analysts Anticipate Galectin Therapeutics Inc. (NASDAQ:GALT) to Announce -$0.06 EPS
www.americanbankingnews.com - September 29 at 11:25 AM |
 | Galectin Therapeutics and Providence Cancer Institute nabs new patent in U.S.
seekingalpha.com - September 17 at 11:34 AM |
| Galectin Therapeutics and Providence Cancer Institute nab new patent in U.S.
seekingalpha.com - September 17 at 11:34 AM |
 | Galectin Therapeutics, Inc. and Providence Cancer Institute Receive Patent on the Use of Belapectin (GR-MD-02) in Cancer Immunotherapy
finance.yahoo.com - September 17 at 11:34 AM |
| Need To Know: Galectin Therapeutics, Inc. (NASDAQ:GALT) Insiders Have Been Buying Shares
finance.yahoo.com - August 27 at 10:27 PM |
| Galectin holders file to offer up to 1.7M shares
seekingalpha.com - August 10 at 5:38 AM |
| Galectin Therapeutics Submits Phase 3 NASH-RX Protocol in Nash Cirrhosis to FDA
finance.yahoo.com - August 5 at 8:53 AM |
| Galectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant Exercise
finance.yahoo.com - May 28 at 9:32 AM |
| What Type Of Shareholder Owns Galectin Therapeutics, Inc.'s (NASDAQ:GALT)?
finance.yahoo.com - May 27 at 5:41 PM |
| Galectin sets lower price in rights offering
seekingalpha.com - May 24 at 8:00 AM |
| Galectin Therapeutics Reports Alternate Price of Common Stock in Rights Offering
finance.yahoo.com - May 23 at 7:43 PM |
| Galectin Therapeutics: Primed For Takeoff After The Rights Offering And New Clinical Evidence
seekingalpha.com - May 15 at 5:49 PM |
| Galectin Therapeutics misses by $0.06
seekingalpha.com - May 10 at 9:57 AM |
| Galectin Therapeutics Reports Q1 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 9:57 AM |
| Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders Dated May 10, 2019
finance.yahoo.com - May 10 at 9:57 AM |
| Galectin Therapeutics Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of its Registration Statement
finance.yahoo.com - April 15 at 8:06 AM |
| Galectin Therapeutics And Belapectin In Phase 3 NASH Cirrhosis: Moving Up
seekingalpha.com - April 11 at 5:42 PM |
| The Galectin Signature
seekingalpha.com - April 9 at 8:00 AM |
| Galectin readies subscription rights offering
seekingalpha.com - April 8 at 8:10 PM |
| Galectin Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 2 at 1:01 PM |
| Galectin Therapeutics, Inc. (GALT)
finance.yahoo.com - April 1 at 5:23 PM |
| Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology
finance.yahoo.com - March 22 at 10:26 AM |
 | Galectin Therapeutics Inc
www.bloomberg.com - March 19 at 10:36 AM |
 | Galectin Therapeutics Inc. Estimate Momentum
www.nasdaq.com - March 18 at 5:46 PM |
| Galectin In NASH, And The Market Assessment
seekingalpha.com - March 15 at 5:48 PM |
| Investors Who Bought Galectin Therapeutics Shares Three Years Ago Are Now Up 248%
finance.yahoo.com - March 6 at 5:52 PM |
 | BRIEF-Galectin Therapeutics Files For Offering Of Units To Purchase Common Shares Of Up To $75 Mln
www.msn.com - March 6 at 9:58 AM |
| Galectin files for rights offering; shares down 1% premarket
seekingalpha.com - March 6 at 9:58 AM |
| Galectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and Warrants
finance.yahoo.com - March 6 at 9:58 AM |
| Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders
finance.yahoo.com - March 6 at 9:58 AM |
| Galectin Therapeutics Likely To Appreciate On Clinical Results, Further Partnerships
seekingalpha.com - February 20 at 5:45 PM |
| Gilead's Mousetrap
seekingalpha.com - February 15 at 9:53 AM |
| AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA
finance.yahoo.com - February 1 at 5:40 PM |
| Is Galectin Therapeutics (GALT) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - January 30 at 5:27 PM |
| Galectin Therapeutics’ Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital Structure
finance.yahoo.com - January 15 at 9:11 AM |
| Did Galectin Therapeutics, Inc. (NASDAQ:GALT) Insiders Sell Shares?
finance.yahoo.com - December 25 at 5:17 PM |
 | Form 8-K GALECTIN THERAPEUTICS For: Dec 20 - StreetInsider.com
www.streetinsider.com - December 21 at 8:27 AM |
 | Galectin Therapeutics Announces Extension of $10 Million Line Credit - GlobeNewswire
globenewswire.com - December 21 at 8:27 AM |
| BRIEF-Galectin Announces Extension Of $10 Million Line Credit
www.msn.com - December 20 at 5:34 PM |
| Galectin Therapeutics Announces Extension of $10 Million Line Credit
finance.yahoo.com - December 20 at 8:42 AM |
| GALECTIN THERAPEUTICS INC.
www.streetinsider.com - November 14 at 8:00 AM |
| Galectin Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 8:01 AM |
| Galectin up 10% on upcoming data presentation supporting utility of breath test in NASH
seekingalpha.com - November 5 at 5:31 PM |
 | Galectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment Conference
feeds.benzinga.com - October 15 at 10:49 AM |
| Galectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment Conference
finance.yahoo.com - October 15 at 8:13 AM |
| Market Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - October 11 at 8:01 AM |
| Form 424B3 GALECTIN THERAPEUTICS
www.streetinsider.com - September 26 at 5:12 PM |
| Galectin's GR-MD-02 Positive in Phase Ib Study With Keytruda
www.msn.com - September 21 at 5:09 PM |
| Your Cancer Highlight: Galectin Surprises With Early-Stage Collaborative Data
seekingalpha.com - September 21 at 5:09 PM |
